Skip to content
ppharmaranks
Menu

Best treatments for ocular hypertension

7 products may treat ocular hypertension, spanning FDA drug classes such as alpha-adrenergic agonist, osmotic diuretic. The current highest-rated option is iopidine. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 7 drugs we list for ocular hypertension, 1 is available as lower-cost generics, spanning classes such as alpha-adrenergic agonist, osmotic diuretic. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for ocular hypertension — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate
Treatments we list for ocular hypertension
#DrugRatingPharmacy pays
170/100$10View →
2Not yet ratedView →
3Not yet ratedView →
4Not yet ratedView →
5Not yet ratedView →
6Not yet ratedView →
7Not yet ratedView →

Narrow by drug class

Explore the class hubs: osmotic diuretic

Full ranking · 7 treatments

Frequently asked

What treats ocular hypertension?
Our catalog lists 7 products that may treat ocular hypertension, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is iopidine.
What is the best-rated treatment for ocular hypertension?
By our independent recall-safety rating — not an efficacy measure — iopidine ranks highest among the products we list for ocular hypertension. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat ocular hypertension?
Treatments for ocular hypertension span FDA drug classes including alpha-adrenergic agonist, osmotic diuretic. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.